SCP
Seizert Capital Partners Portfolio holdings
AUM
$2.37B
1-Year Est. Return
17.44%
This Fund
S&P 500
1 Year Est. Return
+17.44%
AUM
$2.31B
AUM Growth
+$33.1M
(+1.5%)
Holding
187
Top Buys
| 1 | +$37.9M | |
| 2 | +$17.6M | |
| 3 | +$14M | |
| 4 |
Cigna
CI
|
+$13.5M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$9.49M |
Top Sells
| 1 | +$46.7M | |
| 2 | +$40.4M | |
| 3 | +$39.5M | |
| 4 |
WESCO International
WCC
|
+$11.9M |
| 5 |
JPMorgan Chase
JPM
|
+$11.7M |
Sector Composition
| 1 | Technology | 22.73% |
| 2 | Financials | 19.76% |
| 3 | Healthcare | 17.74% |
| 4 | Industrials | 13% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Masco
MAS
$12.3B
| $42.3M | 1.83% |
600,537
+1,550
|
|
||
27
Amdocs
DOX
$7.07B
| $41.8M | 1.81% |
509,681
+1,490
|
|
||
28
Elevance Health
ELV
$64.9B
| $41.3M | 1.79% |
127,826
-6,027
|
|
||
29
SS&C Technologies
SSNC
$16.2B
| $40M | 1.73% |
450,970
+70,524
|
|
||
|
30
WESCO International
WCC
$12.9B
| $39.2M | 1.7% |
185,176
-56,591
|
|
||
31
Builders FirstSource
BLDR
$9.09B
| $36.6M | 1.59% |
301,836
+846
|
|
||
32
Bristol-Myers Squibb
BMY
$121B
| $32.4M | 1.41% |
719,392
+6,604
|
|
||
33
Albertsons Companies
ACI
$8.78B
| $32M | 1.39% |
1,828,935
+5,331
|
|
||
34
Crown Holdings
CCK
$11.4B
| $29.7M | 1.28% |
307,002
+987
|
|
||
35
Leidos
LDOS
$19.8B
| $21M | 0.91% |
111,159
-10,459
|
|
||
36
Robert Half
RHI
$2.54B
| $17.9M | 0.77% |
525,727
-1,496
|
|
||
37
Meta Platforms (Facebook)
META
$1.39T
| $15.6M | 0.67% |
21,212
-2,211
|
|
||
38
Check Point Software Technologies
CHKP
$15.3B
| $15.5M | 0.67% |
75,088
-7,230
|
|
||
39
Brady Corp
BRC
$3.88B
| $15.1M | 0.66% |
193,892
-14,569
|
|
||
40
Graham Holdings Company
GHC
$4.65B
| $14.2M | 0.61% |
12,041
-238
|
|
||
41
Microsoft
MSFT
$2.72T
| $13.3M | 0.58% |
25,723
-3,275
|
|
||
42
F5
FFIV
$16.6B
| $13.1M | 0.57% |
40,658
-5,546
|
|
||
43
Exelixis
EXEL
$11B
| $12.1M | 0.52% |
291,862
-55,227
|
|
||
44
CVS Health
CVS
$90.6B
| $11.4M | 0.49% |
150,792
-3,368
|
|
||
45
Donaldson
DCI
$9.81B
| $11.3M | 0.49% |
137,674
+1,653
|
|
||
46
Lam Research
LRCX
$264B
| $10.5M | 0.46% |
78,716
-39,475
|
|
||
47
Emcor
EME
$32.3B
| $10.2M | 0.44% |
15,683
-5,503
|
|
||
48
Fox Class A
FOXA
$24.9B
| $10.1M | 0.44% |
160,449
-2,936
|
|
||
|
49
Neurocrine Biosciences
NBIX
$13.3B
| $9.83M | 0.43% |
+70,035
|
|
||
50
T. Rowe Price
TROW
$19.6B
| $8.95M | 0.39% |
87,194
-38,255
|
|